Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54,790,889
-
Total 13F shares
-
8,621,122
-
Share change
-
+8,608,782
-
Total reported value
-
$160,437,942
-
Price per share
-
$18.61
-
Number of holders
-
42
-
Value change
-
+$160,207,942
-
Number of buys
-
41
Institutional Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q1 2014
As of 31 Mar 2014,
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,621,122 shares.
The largest 10 holders included
RHO CAPITAL PARTNERS INC, FMR LLC, Lloyds Banking Group plc, FRANKLIN RESOURCES INC, JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, WALL STREET ASSOCIATES, TIVERTON ASSET MANAGEMENT LLC, WELLINGTON MANAGEMENT CO LLP, and GREAT POINT PARTNERS LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.